Cargando…

A Quantitative Increase in Regulatory T Cells Controls Development of Vitiligo

T cell cytolytic activity targeting epidermal melanocyte is shown to cause progressive depigmentation and autoimmune vitiligo. Using the recently developed transgenic mice h3TA2 that carry T cell with a HLA-A2 restricted human tyrosinase reactive TCR and develop spontaneous vitiligo from an early ag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chatterjee, Shilpak, Eby, Jonathan, Al-Khami, Amir A., Soloshchenko, Myroslawa, Kang, Hee-Kap, Kaur, Navtej, Naga, Osama, Murali, Anuradha, Nishimura, Michael I., Le Poole, I. Caroline, Mehrotra, Shikhar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989443/ https://www.ncbi.nlm.nih.gov/pubmed/24366614 http://dx.doi.org/10.1038/jid.2013.540

Ejemplares similares

CCL22 to activate Treg migration and suppress depigmentation in vitiligo
por: Eby, Jonathan M., et al.
Publicado: (2015)

Quantitative increase in T regulatory cells enhances bone remodeling in osteogenesis imperfecta
por: Kang, In-Hong, et al.
Publicado: (2022)

CD38: T Cell Immuno-Metabolic Modulator
por: Kar, Anwesha, et al.
Publicado: (2020)

CD38-NAD(+)-Sirt1 axis in T cell immunotherapy
por: Chatterjee, Shilpak, et al.
Publicado: (2019)

Dynamic Metabolism in Immune Response
por: Al-Hommrani, Mazen, et al.
Publicado: (2016)

Antigen Specificity Enhances Disease Control by Tregs in Vitiligo
por: Mukhatayev, Zhussipbek, et al.
Publicado: (2020)

Interferon-Gamma (IFN-γ)-Mediated Retinal Ganglion Cell Death in Human Tyrosinase T Cell Receptor Transgenic Mouse
por: Husain, Shahid, et al.
Publicado: (2014)

Deletion of Pim Kinases Elevates the Cellular Levels of Reactive Oxygen Species and Sensitizes to K-Ras-Induced Cell Killing
por: Song, Jin H., et al.
Publicado: (2014)

Tumour necrosis factor‐α inhibition can stabilize disease in progressive vitiligo
por: Webb, K.C., et al.
Publicado: (2015)

Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control
por: Kesarwani, Pravin, et al.
Publicado: (2016)

Editorial: Immunology of Vitiligo
por: Seneschal, Julien, et al.
Publicado: (2021)

Clinical and Molecular Aspects of Vitiligo Treatments
por: Bishnoi, Anuradha, et al.
Publicado: (2018)

Melanocyte-keratinocyte cross-talk in vitiligo
por: Touni, Ahmed Ahmed, et al.
Publicado: (2023)

Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor Activity
por: Chakraborty, Paramita, et al.
Publicado: (2019)

Hematopoietic Stem Cells as a Novel Source of Dental Tissue Cells
por: Wilson, Katie R., et al.
Publicado: (2018)

In vitro effect of immune regulatory cytokines on vitiligo pathogenesis
por: Singh, Mala, et al.
Publicado: (2014)

Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8(+) T Cells
por: Chowdhury, Snehanshu, et al.
Publicado: (2022)

COVID-19 Pandemic and Vitiligo: Changing Paradigms
por: Narayan, R Vignesh, et al.
Publicado: (2022)

Chemical Vitiligo: A Subset of Vitiligo
por: Ghosh, Sanjay
Publicado: (2020)

Vitiligo and social acceptance
por: Bidaki, Reza, et al.
Publicado: (2018)

Vitiligo Extent Tensity Index (VETI) score: a new definition, assessment and treatment evaluation criteria in vitiligo
por: Feily, Amir
Publicado: (2014)

Vitiligo /
por: Valderrabano Guitian, Agustín
Publicado: (1987)

Assessing the dynamic changes in vitiligo: reliability and validity of the Vitiligo Disease Activity Score (VDAS) and Vitiligo Disease Improvement Score (VDIS)
por: van Geel, N., et al.
Publicado: (2022)

Meta-Analysis of Alterations in Regulatory T Cells' Frequency and Suppressive Capacity in Patients with Vitiligo
por: Giri, Prashant S., et al.
Publicado: (2022)

The use of lasers in vitiligo, an overview
por: Post, N.F., et al.
Publicado: (2022)

Eyelash Transplantation for the Treatment of Vitiligo Associated Eyelash Leucotrichia
por: Chatterjee, Manas, et al.
Publicado: (2016)

Vitíligo : revisión bibliográfica
por: Merales Aldana, Arturo
Publicado: (1995)

Vitiligo : revisión bibliográfica
por: Huerta Herrera, Alejandrina
Publicado: (2001)

The Vitiligo in Senegal
por: Niang, S. O., et al.
Publicado: (2012)

Inflammatory Vitiligo
por: Chang, Hua-Ching, et al.
Publicado: (2022)

Leucasmus or Vitiligo
por: Earle, Chas. W.
Publicado: (1880)

Proteomic Analysis of the Serum of Patients with Stable Vitiligo and Progressive Vitiligo
por: Li, Yi-Lei, et al.
Publicado: (2018)

Follicular vitiligo: dermatoscopic features of a new subtype of vitiligo
por: Cabrera, Raúl, et al.
Publicado: (2019)

Decreased Circulating T Regulatory Cells in Egyptian Patients with Nonsegmental Vitiligo: Correlation with Disease Activity
por: Hegab, Doaa Salah, et al.
Publicado: (2015)

Integrative Analysis of Omics Data Reveals Regulatory Network of CDK10 in Vitiligo Risk
por: Cai, Minglong, et al.
Publicado: (2021)

The relationship between stress and vitiligo: Evaluating perceived stress and electronic medical record data
por: Henning, Steven W., et al.
Publicado: (2020)

Vitiligo-Associated Autoimmune Disorders: A Woman With Vitiligo and Incipient Hypothyroidism
por: Malik, Sara, et al.
Publicado: (2021)

TMT-Based Quantitative Proteomic and Physiological Analyses on Serums of Chinese Patients with Active Vitiligo
por: Chen, Zile, et al.
Publicado: (2023)

Management of Vitiligo Amidst the COVID-19 Pandemic: A Survey and Resulting Consensus
por: Chatterjee, Manas, et al.
Publicado: (2021)

ASYMPTOMATIC PAPULES AND PLAQUE IN A PATIENT WITH GENERALIZED VITILIGO
por: Reddy, I S, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_k8skqgdp0e1om6vr64tbogkvk0